Scientists at Johns Hopkins Bloomberg School of Public Health have developed a test which takes a close look at smaller molecules called "metabolites" to determine if diets that doctors have prescribed to patients are being committed to or not.
Dietitians, nutritionists and other doctors assigned to or conducting medical trials on diets assigned to patients with various conditions are often proven to be a large inconvenience due to being unable to tell if a certain diet is actually working or not, or if a patient is staying true to the diet prescribed and not eating foods a doctor would recommend against.
A new test has surfaced which proves that it is possible to tell if patients are following a diet by taking a look and analyzing metabolites which would severely cut down on the number of unnecessary tests and errors which usually arise under normal conditions. Johns Hopkins Bloomberg School of Public Health conducted tests which proved that there was a difference in metabolite levels between those being treated regularly and between groups being controlled in a trial based around the popular DASH diet.
The study proved that the difference in the level of metabolites between the groups varied in the dozens. Casey M. Rebholz, lead author of the metabolite study and an assistant professor at the Johns Hopkins Bloomberg school said: "We can now consider these metabolites as candidate biomarkers for assessing adherence to the DASH diet in future nutrition research studies, and one day clinicians might use these markers to monitor what their patients eat."
The test was developed as a means of determining what a patient was eating under a prescribed diet as many of those dieting tend to bend the truth about what foods they've consumed at any given time. Casey M. Rebholz also spoke more, saying that "There was a clear differentiation in metabolite profiles between the DASH diet and the control diet," when referring to the differences.